iGlarLixi versus Basal Plus Rapid-Acting Insulin in Adults with Type 2 Diabetes Advancing from Basal Insulin Therapy: The SoliSimplify Real-World Study

Rory McCrimmon (Lead / Corresponding author), Alice Y. Y. Cheng, Gagik R. Galstyan, Khier Djaballah, Xuan Li, Mathieu Coudert, Juan P. Frias

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)
    189 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'iGlarLixi versus Basal Plus Rapid-Acting Insulin in Adults with Type 2 Diabetes Advancing from Basal Insulin Therapy: The SoliSimplify Real-World Study'. Together they form a unique fingerprint.

    Keyphrases

    Nursing and Health Professions

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science

    Food Science